Prof., Executive VP of R&D and Founder of NanoPharmaceuticals LLC
PRI at ACPHS & NanoPharmaceuticals LLC
Rensselare, New York
DR MOUSA is a tenured professor of Pharmacology at Albany College of Pharmacy, Executive VP and chair of PRI at Albany, NY. Dr. Mousa is the founder of the Pharmaceutical Research Institute in 2002 and the founders of spin-off Pharmaceutical and biotechnology companies. He held a senior, principal research scientist and a research fellow at DuPont Pharmaceuticals and Imaging Co., DuPont Merck, and DuPont Pharmaceuticals Company for two decades. Awarded the 2017 Kuwait Foundation for Advancement in Sciences (KFAS) Laureate for Applied Sciences in Medicine. Awarded in 2018 fellow of the National Academy of Inventors (FNAI), Awarded in 2020 the first Sheikh Zayed International Award in Traditional Complementary and Alternative Medicine (TCAM). In 2020-2021, Dr. Mousa ranked by Stanford ranking to be among the top 1% of globally impactful scientist.
Among Dr Mousa’s professional accomplishments are his contributions to several patents and to the discovery and development of novel anti-platelet, anti-thrombotic therapies, noninvasive myocardial perfusion, and thrombus imaging agents. His work is reported in over 1,000 peer-reviewed publications and holds over 400 US Patents and International Patents. He contributed to the discovery and development of FDA approved products / clinical candidates.
Disclosure information not submitted.
Monday, October 17, 2022
9:30 AM – 10:00 AM ET